After adjusting for factors like age and sex, GLP-1 users had a noticeably higher risk of later alopecia than either group of diabetes patients, the researchers found
Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its investigational obesity drug MariTide will continue to provide competitive weight loss even at monthly or longer schedules
A detailed medical history should be taken before initiating retatrutide, with particular attention paid to previous digestive or gallbladder issues
RETATRUTIDE RETATRUTIDE Retatrutide Research Grade Peptide Retatrutide is an investigational amino acid peptide studied as a triple hormone receptor agonist, simultaneously targeting the GLP-1, GIP, and glucagon receptors to evaluate comprehensive metabolic effects in research
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy